West Pharmaceutical Services, Inc. (BVMF:W2ST34)

Market Cap	90.76B -6.2%
Revenue (ttm)	16.93B +6.3%
Net Income	2.72B +0.2%
EPS	37.40 +1.5%
Shares Out	n/a
PE Ratio	33.38
Forward PE	29.77
Dividend	0.09 (0.26%)
Ex-Dividend Date	Jan 27, 2026

Volume	1
Average Volume	117
Open	35.76
Previous Close	35.36
Day's Range	35.76 - 35.76
52-Week Range	33.51 - 48.04
Beta	1.18
RSI	41.34
Earnings Date	Apr 30, 2026

About BVMF:W2ST34

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhanc...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1923
• Employees: 10,800
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: W2ST34

Financial Performance

In 2025, BVMF:W2ST34's revenue was $3.07 billion, an increase of 6.25% compared to the previous year's $2.89 billion. Earnings were $493.70 million, an increase of 0.20%.

Financial numbers in USD